{
  "docId": "019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "docSlug": "78e7004510e3b27003e9c94a6172e682",
  "documentTitle": "Chimerix | Investor Presentation Deck | 38 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 38,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": "Data presented includes ORR, DOR, time to response, disease control rate, PFS, and overall survival metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-80bf-72b8-b7b1-d0f771f9e60f/7",
  "deckHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "deckJsonHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f.json",
  "deckAnchorHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.085,
        "w": 0.415,
        "x": 0.052,
        "y": 0.588
      },
      "kind": "list",
      "text": "Overall survival: 12 months: 57% (95% CI:41 – 70%); 24 months: 35% (95% CI: 21 – 49%)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c2d27f9-c695-4bf2-8b1f-4616b8763774",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.285,
        "w": 0.835,
        "x": 0.052,
        "y": 0.228
      },
      "kind": "list",
      "text": "RANO-HGG criteria assessed by dual reader BICR: ORR 20%, DOR 11.2 months, time to response 8.3 months, disease control 40%, PFS 6mo 35%, PFS 12mo 30%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4937fd4e-58d8-4ded-93f5-9db75f5116e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.941,
        "x": 0.052,
        "y": 0.178
      },
      "kind": "list",
      "text": "Overall Response Rate (ORR) of 30% (95% CI: 18 - 45%) by RANO HGG and/or LGG dual reader BICR",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49e00252-6c9d-4068-a570-5875d6da796f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.926,
        "x": 0.052,
        "y": 0.128
      },
      "kind": "list",
      "text": "ONC201 monotherapy exhibited durable, clinically meaningful efficacy in recurrent H3 K27M-mutant DMG",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e1af3a3-12ec-4793-bfa9-9c4a9ffa630b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.728,
        "x": 0.024,
        "y": 0.798
      },
      "kind": "list",
      "text": "Improvements observed in performance status and reduction in corticosteroid use",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8af6898a-13b0-44e5-9b90-791885149224",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.365,
        "x": 0.052,
        "y": 0.538
      },
      "kind": "list",
      "text": "RANO-LGG criteria assessed by dual reader BICR: ORR 26% (95% CI: 15 – 40%)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d2d9d39-a8de-4e83-a1aa-7250346e5268",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.512,
        "x": 0.024,
        "y": 0.848
      },
      "kind": "list",
      "text": "All SAEs considered not related to ONC201 by sponsor",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e90b6dc9-39f0-4b30-a36c-b9f28ab6be55",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.038,
        "w": 0.784,
        "x": 0.108,
        "y": 0.065
      },
      "kind": "title",
      "text": "Phase 2 efficacy for ONC201 in recurrent H3 K27M DMG",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1eae8cff-6eeb-4500-aaaa-302bba00f4a0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f6a8f593-24ff-4f4f-b6ee-74f5bed42c85",
      "evidence": "list/bullet: RANO-HGG criteria assessed by dual reader BICR: ORR 20%, DOR 11.2 months, time to response 8.3 months, disease control 40%, PFS 6mo 35%, PFS 12mo 30%",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "6b90c7d3-b52c-4de1-84f0-3c0bd838a394",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the limited efficacy of current treatments.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2bc9dab0-eaf0-4e1c-a235-49723ff2f884",
      "evidence": "The document highlights the high unmet need and limited efficacy of current treatments.",
      "position": 0,
      "objective": "What are the consequences of not treating H3 K27M-mutant diffuse glioma effectively?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}